BioCryst Pharmaceuticals
BCRX
BCRX
112 hedge funds and large institutions have $370M invested in BioCryst Pharmaceuticals in 2016 Q4 according to their latest regulatory filings, with 19 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 9 closing their positions.
Holders
112
Holders Change
+9
Holders Change %
+8.74%
% of All Funds
2.8%
Holding in Top 10
4
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+33.33%
% of All Funds
0.1%
New
19
Increased
37
Reduced
28
Closed
9
Calls
$25.2M
Puts
$8.02M
Net Calls
+$17.1M
Net Calls Change
+$17.5M
Top Buyers
Top Sellers
1 |
DM
1
Deerfield Management
New York
|
$20.5M |
2 |
GTC
2
Ghost Tree Capital
New York
|
$7.28M |
3 |
ACP
3
Acuta Capital Partners
Redwood City,
California
|
$950K |
4 |
PC
4
Paulson & Co
New York
|
$333K |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$21.3M |